NeoGenomics is trading 5.44% higher at $19.92 after closing at $18.89 on September 22, 2026; no confirmed company-specific announcement or news explains the after-hours jump.

  • Recent coverage focused on Morgan Stanley conference commentary about NGS and MRD growth, but the event occurred earlier and does not clearly explain the move.
  • The broader market was muted, making macro sentiment unlikely to be the primary catalyst.